Report Detail
Global Mirvetuximab Soravtansine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706254 |
- 09 June, 2026 |
- Global |
- 83 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Mirvetuximab Soravtansine market size was valued at US$ 710 million in 2025 and is forecast to a readjusted size of US$ 2621 million by 2032 with a CAGR of 15.9% during review period.
Mirvetuximab Soravtansine is an antibody-drug conjugate (ADC) targeting folate receptor α (FRα). It is covalently formed by conjugating a humanized anti-FRα monoclonal antibody, a cleavable linker, and the microtubule inhibitor DM4. The drug can specifically recognize and bind to highly expressed FRα on the surface of tumor cells, release cytotoxic payloads after endocytosis into cells, and precisely kill tumor cells. It is mainly used for the treatment of malignant tumors such as FRα-positive recurrent ovarian cancer. Featuring high targeting ability and strong anti-tumor activity, it provides an important targeted therapeutic option for patients with advanced ovarian cancer.In 2025, global Mirvetuximab Soravtansine production reached approximately 105,000–110,000 vials.
As a globally pioneering and the only approved FRα-targeted ADC drug, Mirvetuximab Soravtansine has established significant clinical and market advantages in the field of platinum-resistant ovarian cancer. Its core value lies in the high efficacy and low toxicity profile brought by its precise targeting mechanism, which effectively addresses the long-unmet clinical needs. The global market is mainly led by the United States, and with successive approvals and commercialization in major markets such as the European Union and China, the product has shown a trend of rapid growth. Supported by priority recommendations in authoritative guidelines, it has further driven continuous improvements in physician prescriptions and patient penetration. In China, the commercialization is led by Huadong Medicine, which has achieved early market access and rapid nationwide coverage through favorable innovative drug policies. The advantages of local channels and academic promotion are gradually unlocking market potential. Looking ahead, its market growth will rely on the continuous penetration of ovarian cancer indications on the one hand, and the potential clinical expansion into other FRα-highly-expressing tumors on the other. Meanwhile, it faces multiple constraints including limited accessibility due to high pricing, the progress of medical insurance coverage, and the development of competing products targeting the same target in the future. Overall, the market is expected to grow steadily while accompanied by uncertainties from competition and policy changes.
This report is a detailed and comprehensive analysis for global Mirvetuximab Soravtansine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mirvetuximab Soravtansine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mirvetuximab Soravtansine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mirvetuximab Soravtansine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Hangzhou Sino-American East China Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mirvetuximab Soravtansine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lyophilized Powder for Injection
Injectable Solution
Market segment by Combination Medication
Mirvetuximab Soravtansine In Combination With Bevacizumab
Mirvetuximab Soravtansine In Combination With Carboplatin
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Application
FRα-Positive Recurrent Ovarian Cancer
Platinum-Resistant Epithelial Ovarian Cancer
FRα-Highly Expressed Advanced Solid Tumors
Others
Major players covered
AbbVie
Hangzhou Sino-American East China Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mirvetuximab Soravtansine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mirvetuximab Soravtansine, with price, sales quantity, revenue, and global market share of Mirvetuximab Soravtansine from 2021 to 2026.
Chapter 3, the Mirvetuximab Soravtansine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mirvetuximab Soravtansine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mirvetuximab Soravtansine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mirvetuximab Soravtansine.
Chapter 14 and 15, to describe Mirvetuximab Soravtansine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Lyophilized Powder for Injection
- 1.3.3 Injectable Solution
- 1.4 Market Analysis by Combination Medication
- 1.4.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Combination Medication: 2021 Versus 2025 Versus 2032
- 1.4.2 Mirvetuximab Soravtansine In Combination With Bevacizumab
- 1.4.3 Mirvetuximab Soravtansine In Combination With Carboplatin
- 1.5 Market Analysis by Sales Channels
- 1.5.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 FRα-Positive Recurrent Ovarian Cancer
- 1.6.3 Platinum-Resistant Epithelial Ovarian Cancer
- 1.6.4 FRα-Highly Expressed Advanced Solid Tumors
- 1.6.5 Others
- 1.7 Global Mirvetuximab Soravtansine Market Size & Forecast
- 1.7.1 Global Mirvetuximab Soravtansine Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Mirvetuximab Soravtansine Sales Quantity (2021-2032)
- 1.7.3 Global Mirvetuximab Soravtansine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 AbbVie
- 2.1.1 AbbVie Details
- 2.1.2 AbbVie Major Business
- 2.1.3 AbbVie Mirvetuximab Soravtansine Product and Services
- 2.1.4 AbbVie Mirvetuximab Soravtansine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 AbbVie Recent Developments/Updates
- 2.2 Hangzhou Sino-American East China Pharmaceutical
- 2.2.1 Hangzhou Sino-American East China Pharmaceutical Details
- 2.2.2 Hangzhou Sino-American East China Pharmaceutical Major Business
- 2.2.3 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
- 2.2.4 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Mirvetuximab Soravtansine by Manufacturer
- 3.1 Global Mirvetuximab Soravtansine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Mirvetuximab Soravtansine Revenue by Manufacturer (2021-2026)
- 3.3 Global Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Mirvetuximab Soravtansine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Mirvetuximab Soravtansine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Mirvetuximab Soravtansine Manufacturer Market Share in 2025
- 3.5 Mirvetuximab Soravtansine Market: Overall Company Footprint Analysis
- 3.5.1 Mirvetuximab Soravtansine Market: Region Footprint
- 3.5.2 Mirvetuximab Soravtansine Market: Company Product Type Footprint
- 3.5.3 Mirvetuximab Soravtansine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Mirvetuximab Soravtansine Market Size by Region
- 4.1.1 Global Mirvetuximab Soravtansine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Mirvetuximab Soravtansine Consumption Value by Region (2021-2032)
- 4.1.3 Global Mirvetuximab Soravtansine Average Price by Region (2021-2032)
- 4.2 North America Mirvetuximab Soravtansine Consumption Value (2021-2032)
- 4.3 Europe Mirvetuximab Soravtansine Consumption Value (2021-2032)
- 4.4 Asia-Pacific Mirvetuximab Soravtansine Consumption Value (2021-2032)
- 4.5 South America Mirvetuximab Soravtansine Consumption Value (2021-2032)
- 4.6 Middle East & Africa Mirvetuximab Soravtansine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
- 5.2 Global Mirvetuximab Soravtansine Consumption Value by Type (2021-2032)
- 5.3 Global Mirvetuximab Soravtansine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
- 6.2 Global Mirvetuximab Soravtansine Consumption Value by Application (2021-2032)
- 6.3 Global Mirvetuximab Soravtansine Average Price by Application (2021-2032)
7 North America
- 7.1 North America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
- 7.2 North America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
- 7.3 North America Mirvetuximab Soravtansine Market Size by Country
- 7.3.1 North America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
- 8.2 Europe Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
- 8.3 Europe Mirvetuximab Soravtansine Market Size by Country
- 8.3.1 Europe Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Mirvetuximab Soravtansine Market Size by Region
- 9.3.1 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Mirvetuximab Soravtansine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
- 10.2 South America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
- 10.3 South America Mirvetuximab Soravtansine Market Size by Country
- 10.3.1 South America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Mirvetuximab Soravtansine Market Size by Country
- 11.3.1 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Mirvetuximab Soravtansine Market Drivers
- 12.2 Mirvetuximab Soravtansine Market Restraints
- 12.3 Mirvetuximab Soravtansine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Mirvetuximab Soravtansine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Mirvetuximab Soravtansine
- 13.3 Mirvetuximab Soravtansine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Mirvetuximab Soravtansine Typical Distributors
- 14.3 Mirvetuximab Soravtansine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Mirvetuximab Soravtansine. Industry analysis & Market Report on Mirvetuximab Soravtansine is a syndicated market report, published as Global Mirvetuximab Soravtansine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Mirvetuximab Soravtansine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
